VERBRÜCKTE PIPERIDINDERIVATE

European patent · EP3519418 · In force

Register entry

Publication number
EP3519418
Application number
EP17772729
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 28, 2017
Published
Aug 7, 2019
Granted
Dec 8, 2021
Protection ends at the latest
Sep 27, 2037
Next annual fee due
Sep 30, 2027
IPC classes
C07D 519/00 (2006.01)
A61K 31/4196 (2006.01)
A61P 25/28 (2006.01)
Priority
EP 16191512 29.09.2016
PCT application
PCT/EP2017/074575 28.09.2017
PCT publication
WO2018/060300 05.04.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  4. Oct 1, 2023

    Change

    Published in Swissreg on 01.10.2023

  5. Oct 19, 2022

    Change

    Published in Swissreg on 19.10.2022

  6. Oct 1, 2022

    Change

    Published in Swissreg on 01.10.2022

  7. Dec 8, 2021

    Granted

    Published in Swissreg on 08.12.2021

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

BARTELS, Bjoern

4070 Basel

JAKOB-ROETNE, Roland

4070 Basel

NEIDHART, Werner

4070 Basel

RATNI, Hasane

4070 Basel

LIMBERG, Anja

4070 Basel

VASTAKAITE, Greta

8093 Zurich

REUTLINGER, Michael

4070 Basel

SARIE, Jérôme Charles

4070 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.